Sorrento Therapeutics, Inc. - SRNE

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2026 · Compare: Q4 2025
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
VSM Wealth Advisory, LLC History New 110,100 0 +110,100 New Q1 2026 May 05, 2026
KINGSWOOD WEALTH ADVISORS, LLC History Closed out 0 0 -25,650 -100.0% Q1 2026 Apr 28, 2026
Ancora Advisors LLC History Closed out 0 0 -5 -100.0% Q1 2026 May 15, 2026
HUNTINGTON NATIONAL BANK History No change 5,001 0 0 0.0% Q1 2026 May 15, 2026
Oakworth Capital, Inc. History No change 350 0 0 0.0% Q1 2026 Apr 24, 2026
Financial Gravity Asset Management, Inc. History No change 18 0 0 0.0% Q1 2026 May 08, 2026